Every 424B that Dyadic International, Inc. (DYAI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow DYAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DYAI filings page.
Dyadic International, Inc. (DYAI) is registering up to 3,625,000 shares of common stock for resale by existing holders, issuable upon exercise of warrants with an exercise price of $0.84 per share. These are secondary sales; Dyadic is not selling any shares in this offering.
The selling stockholders may dispose of shares from time to time at market or negotiated prices using various methods, including brokered and privately negotiated transactions. Dyadic will receive cash only if the warrants are exercised, and any resale proceeds will go solely to the selling stockholders.
Dyadic International, Inc. is conducting a registered direct primary offering of 3,625,000 shares of common stock at $0.795 per share, for gross proceeds of $2,881,875. Aegis Capital Corp. acts as placement agent on a reasonable best efforts basis and receives a 7% cash fee.
Concurrently, Dyadic will sell in a private placement warrants to purchase 3,625,000 shares at an exercise price of $0.84, at $0.005 per warrant. Each closing is contingent on the other. After placement fees and estimated expenses, Dyadic expects net proceeds of approximately $2.28 million, to be used for general corporate purposes including R&D, sales and marketing, working capital, capital expenditures, and potential acquisitions.
Shares outstanding will increase from 36,438,703 to 40,063,703, and the company highlights immediate and substantial dilution of $0.80 per share to new investors based on its June 30, 2026 net tangible book deficit. Executives, directors, key holders, and the company are generally subject to 90-day lock-up and standstill provisions, and Aegis receives a nine‑month right of first refusal on certain future financings.
Dyadic International, Inc. has filed a prospectus supplement to offer up to $4,237,818 of common stock in an at-the-market offering through Craig-Hallum Capital Group LLC as sales agent.
The sales agreement permits sales from time to time at prevailing market prices, with Craig-Hallum paid up to 3.0% commission. The prospectus supplement notes the public float calculation that limits sales under Form S-3 to one-third of public float and explains that Dyadic previously sold $5,749,400 in the prior 12 months, leaving an available capacity of $4,237,818 under the applicable instruction.